{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:26:02Z","timestamp":1793013962258,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.beem.2024.101878","type":"journal-article","created":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T16:57:05Z","timestamp":1707843425000},"page":"101878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["\u201cMicromegaly\u201d: Acromegaly with apparently normal GH, an entity on its own?"],"prefix":"10.1016","volume":"38","author":[{"given":"Lucio","family":"Vilar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Ansaneli","family":"Naves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoel Ricardo Alves","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f4nio","family":"Ribeiro-Oliveira Jr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.beem.2024.101878_bib1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ecl.2007.10.002","article-title":"Acromegaly","volume":"37","author":"Ben-Shlomo","year":"2008","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"10.1016\/j.beem.2024.101878_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11102-017-0789-7","article-title":"The genetic background of acromegaly","volume":"20","author":"Gadelha","year":"2017","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.beem.2024.101878_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41572-019-0071-6","article-title":"Acromegaly","volume":"5","author":"Colao","year":"2019","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.beem.2024.101878_bib4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1530\/EJE-22-0440","article-title":"Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients","volume":"187","author":"Burman","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"24","key":"10.1016\/j.beem.2024.101878_bib5","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMra062453","article-title":"Medical progress: acromegaly","volume":"355","author":"Melmed","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beem.2024.101878_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.867965","article-title":"Acromegaly caused by ectopic growth hormone releasing hormone secretion: a review","volume":"13","author":"Zendran","year":"2022","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2024.101878_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM198501033120103","article-title":"Acromegaly due to secretion of growth hormone by an ectopic pancreatic islet-cell tumor","volume":"312","author":"Melmed","year":"1985","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.beem.2024.101878_bib8","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1056\/NEJM200006223422504","article-title":"Acromegaly caused by secretion of growth hormone by a non-Hodgkin\u2019s lymphoma","volume":"342","author":"Beuschlein","year":"2000","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.beem.2024.101878_bib9","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an Endocrine Society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2024.101878_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11102-016-0772-8","article-title":"Acromegaly: clinical features at diagnosis","volume":"20","author":"Vilar","year":"2017","journal-title":"Pituitary"},{"issue":"6","key":"10.1016\/j.beem.2024.101878_bib11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s11102-016-0735-0","article-title":"Micromegaly\u201d: an update on the prevalence of acromegaly with apparently normal GH secretion in the modern era","volume":"19","author":"Butz","year":"2016","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2024.101878_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/EJE-19-0139","article-title":"Determinants of the growth hormone nadir during oral glucose tolerance test in adults","volume":"181","author":"Schilbach","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2024.101878_bib13","first-page":"297","article-title":"Sur deux cas d\u00b4acromegalie: hypertrophy singluli\u00e8re non cong\u00e9nitale des extr\u00e9mit\u00e9s sup\u00e9rieurs, inf\u00e9rieurs and c\u00e9phalique","volume":"6","author":"Marie","year":"1886","journal-title":"Rev De M\u00e9d"},{"issue":"5","key":"10.1016\/j.beem.2024.101878_bib14","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3390\/jcm10051147","article-title":"The biochemical diagnosis of acromegaly","volume":"10","author":"Akirov","year":"2021","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.beem.2024.101878_bib15","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/cen.13129","article-title":"The ongoing challenge of discrepant growth hormone and insulin-like growth factor I results in the evaluation of treated acromegalic patients: a systematic review and meta-analysis","volume":"85","author":"Kanakis","year":"2016","journal-title":"Clin Endocrinol"},{"issue":"8","key":"10.1016\/j.beem.2024.101878_bib16","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1210\/jcem.87.8.8658","article-title":"Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up","volume":"87","author":"Dimaraki","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.beem.2024.101878_bib17","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1210\/jc.2018-01113","article-title":"Prevalence, clinical and biochemical spectrum, and treatment outcome of acromegaly with normal basal GH at diagnosis","volume":"103","author":"Espinosa de Los Monteros","year":"2018","journal-title":"J Clin Endocrinolol Metab"},{"issue":"2","key":"10.1016\/j.beem.2024.101878_bib18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2478\/enr-2022-0010","article-title":"Characteristics and treatment outcomes of micromegaly - acromegaly with apparently normal basal GH: a retrospective study and literature review","volume":"56","author":"Inacio","year":"2022","journal-title":"Endocr Regul"},{"issue":"1","key":"10.1016\/j.beem.2024.101878_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ecl.2014.10.003","article-title":"Pitfalls of insulin-like growth factor-I and growth hormone assays","volume":"44","author":"Junnila","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"10.1016\/j.beem.2024.101878_bib20","first-page":"53","article-title":"Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study","volume":"60","author":"Brabant","year":"2003","journal-title":"Horm Res"},{"issue":"5","key":"10.1016\/j.beem.2024.101878_bib21","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1210\/jc.2013-3059","article-title":"Reference intervals for insulin-like growth factor-1 (IGF-I) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations","volume":"99","author":"Bidlingmaier","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2024.101878_bib22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11102-017-0849-z","article-title":"Discordance between mass spectrometry and immunometric IGF-1 assay in pituitary disease: a prospective study","volume":"21","author":"Bonert","year":"2018","journal-title":"Pituitary"},{"issue":"9","key":"10.1016\/j.beem.2024.101878_bib23","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1210\/jc.2016-1257","article-title":"Reference values for IGF-I serum concentrations: comparison of six immunoassays","volume":"101","author":"Chanson","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2024.101878_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11102-023-01360-1","article-title":"Consensus on criteria for acromegaly diagnosis and remission","volume":"27","author":"Giustina","year":"2024","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2024.101878_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ghir.2022.101467","article-title":"Biochemical discrepancies in the evaluation of the somatotroph axis: elevated GH or IGF-1 levels do not always diagnose acromegaly","volume":"64","author":"Peixe","year":"2022","journal-title":"Growth Horm IGF Res"},{"issue":"6","key":"10.1016\/j.beem.2024.101878_bib26","doi-asserted-by":"crossref","first-page":"618","DOI":"10.20945\/2359-3997000000192","article-title":"Laboratory investigations in the diagnosis and follow-up of GH-related disorders","volume":"63","author":"Shillbach","year":"2019","journal-title":"Arch Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101878_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1266339","article-title":"Interpreting growth hormone and IGF-I results using modern assays and reference ranges for the monitoring of treatment effectiveness in acromegaly","volume":"14","author":"Clemmons","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beem.2024.101878_bib28","series-title":"Endocrinologia Cl\u00ednica (Clinical Endocrinology)","first-page":"79","article-title":"Acromegaly \u2013 An overview","author":"Naves","year":"2021"},{"issue":"6","key":"10.1016\/j.beem.2024.101878_bib29","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1515\/cclm-2016-0606","article-title":"False biochemical diagnosis of hyperthyroidism in streptavidin-biotin-based immunoassays: the problem of biotin intake and related interferences","volume":"55","author":"Piketty","year":"2017","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"10.1016\/j.beem.2024.101878_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3343\/alm.2022.42.1.3","article-title":"Hormone immunoassay interference: a 2021 update","volume":"42","author":"Ghazal","year":"2022","journal-title":"Ann Lab Med"},{"issue":"4","key":"10.1016\/j.beem.2024.101878_bib31","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1210\/jc.2007-2084","article-title":"Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index","volume":"93","author":"Arafat","year":"2008","journal-title":"J Clin Endocrinolol Metab"},{"issue":"2","key":"10.1016\/j.beem.2024.101878_bib32","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1210\/jc.2008-1371","article-title":"The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly","volume":"94","author":"Carmichael","year":"2009","journal-title":"J Clin Endocrinolol Metab"},{"issue":"3","key":"10.1016\/j.beem.2024.101878_bib33","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000497214","article-title":"Growth hormone response to oral glucose load: from normal to pathological conditions","volume":"108","author":"Hage","year":"2019","journal-title":"Neuroendocrinology"},{"issue":"8","key":"10.1016\/j.beem.2024.101878_bib34","doi-asserted-by":"crossref","first-page":"e2887","DOI":"10.1210\/clinem\/dgab257","article-title":"Soluble Alpha Klotho in acromegaly: comparison with traditional markers of disease activity","volume":"106","author":"Schweizer","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2024.101878_bib35","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3803\/EnM.2023.1820","article-title":"Multiomics approach to acromegaly: unveiling translational insights for precision medicine","volume":"38","author":"Kim","year":"2023","journal-title":"Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.beem.2024.101878_bib36","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1055\/s-2007-1003342","article-title":"Acromegaly with normal serum growth hormone levels. Clinical features, diagnosis and results of transsphenoidal microsurgery","volume":"24","author":"Brockmeier","year":"1992","journal-title":"Horm Metab Res"},{"issue":"4","key":"10.1016\/j.beem.2024.101878_bib37","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/B:PITU.0000023424.72021.e2","article-title":"Basal and glucose-suppressed GH levels less than 1 microg\/L in newly diagnosed acromegaly","volume":"6","author":"Freda","year":"2003","journal-title":"Pituitary"},{"issue":"5","key":"10.1016\/j.beem.2024.101878_bib38","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ghir.2008.02.001","article-title":"Prevalence of discordant GH and IGF-I levels in acromegalics at diagnosis, after surgical treatment and during treatment with octreotide LAR","volume":"18","author":"Machado","year":"2008","journal-title":"Growth Horm IGF Res"},{"issue":"1","key":"10.1016\/j.beem.2024.101878_bib39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1530\/EJE-10-0744","article-title":"Limited utility of oral glucose tolerance test in biochemically active acromegaly","volume":"164","author":"Ribeiro-Oliveira","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2024.101878_bib40","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1530\/EJE-21-0024","article-title":"Clinical and hormonal findings in patients presenting with high IGF-1 and growth hormone suppression after oral glucose load: a retrospective cohort study","volume":"185","author":"Carosi","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2024.101878_bib41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11102-014-0564-y","article-title":"The clinical and cardiometabolic effects of d3-growth hormone receptor polymorphism in acromegaly","volume":"18","author":"Cinar","year":"2015","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.beem.2024.101878_bib42","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ghir.2008.10.001","article-title":"Comparison between weight-based and IGF-I-based growth hormone (GH) dosing in the treatment of children with GH deficiency and influence of exon 3 deleted GH receptor variant","volume":"19","author":"Marchisotti","year":"2009","journal-title":"Growth Horm IGF Res"},{"issue":"4","key":"10.1016\/j.beem.2024.101878_bib43","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ecl.2005.07.006","article-title":"Sex-steroid control of the aging somatotropic axis","volume":"34","author":"Veldhuis","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"7","key":"10.1016\/j.beem.2024.101878_bib44","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1210\/jc.2013-1581","article-title":"Complex rhythmicity and age dependence of growth hormone secretion are preserved in patients with acromegaly: further evidence for a present hypothalamic control of pituitary somatotropinomas","volume":"98","author":"Ribeiro-Oliveira","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101878_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ghir.2019.04.002","article-title":"Could calgranulins and advanced glycated end products potentiate acromegaly pathophysiology?","volume":"46-47","author":"Kruse","year":"2019","journal-title":"Growth Horm IGF Res"},{"issue":"6","key":"10.1016\/j.beem.2024.101878_bib46","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4158\/EP11324.OR","article-title":"Serum IGF-1 in the diagnosis of acromegaly and the profile of patients with elevated IGF-1 but normal glucose-suppressed growth hormone","volume":"18","author":"Subbarayan","year":"2012","journal-title":"Endocr Pract"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X24000204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X24000204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T22:59:29Z","timestamp":1715122769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X24000204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1521690X24000204"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2024.101878","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cMicromegaly\u201d: Acromegaly with apparently normal GH, an entity on its own?","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2024.101878","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101878"}}